CHAMBLFERT · Chemicals
The board meets on 3 Nov 2026 to approve the results. This page fills in when the numbers are filed.
| Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ₹5,386 cr | ₹4,349 cr | ₹2,643 cr | ₹4,933 cr | ₹4,346 cr | ₹4,918 cr | ₹2,449 cr | ₹5,698 cr | ₹6,413 cr | ₹5,898 cr | ₹2,785 cr | ₹5,027 cr |
| YoY | — | — | — | −12% | −19% | +13% | −7% | +16% | +48% | +20% | +14% | −12% |
| EBITDA margin | 11.4% | 14.4% | 6.3% | 15.2% | 18.2% | 15.8% | 6.7% | 13.4% | 13.1% | 13.9% | 9.2% | 16.4% |
| Other income, % of PBT | 15% | 23% | 58% | 12% | 10% | 12% | 51% | 10% | 10% | 5% | 25% | 4% |
| Exceptional items | — | — | — | — | — | — | — | — | — | — | — | — |
| Tax rate | 34% | 31% | 23% | 37% | 32% | 32% | 22% | 27% | 23% | 24% | 21% | 30% |
| Net profit | ₹381 cr | ₹459 cr | ₹97.0 cr | ₹448 cr | ₹536 cr | ₹534 cr | ₹130 cr | ₹549 cr | ₹649 cr | ₹586 cr | ₹169 cr | ₹524 cr |
| YoY | — | — | — | +32% | +41% | +16% | +34% | +23% | +21% | +10% | +30% | −5% |
| Core profit YoY | — | — | — | +25% | +44% | +34% | +55% | +7% | +7% | +6% | +98% | +7% |
| EPS | ₹9.15 | ₹11.04 | ₹2.42 | ₹11.19 | ₹13.39 | ₹13.34 | ₹3.25 | ₹13.70 | ₹16.19 | ₹14.64 | ₹4.22 | ₹13.07 |
| Flags | · | · | 2 | ✓ | ✓ | ✓ | 1 | 1 | 1 | ✓ | ✓ | ✓ |
Each quarter is read with the same rules. Balance-sheet and cash checks run on half-year and annual quarters; filing-read checks run where a read exists.
Numbers as filed with the exchanges, read by rules. Every flag is a question with its source, not an accusation. FinMinutes is a financial data and analytics platform; nothing here is a recommendation to buy, sell or hold any security. How each check works.